Publication: A New Generation Chronic Myeloid Leukemia Treatment Strategy Through the Utilization of CRISPR/Cas9 Mediated Gene Therapy
| dc.authorwosid | Yildirim, Mahmut/Aar-7483-2021 | |
| dc.authorwosid | Somuncu, Makbule Nihan/Afj-7461-2022 | |
| dc.authorwosid | Aydin, Cihan/B-2290-2019 | |
| dc.authorwosid | Aydın, Cihan/B-2290-2019 | |
| dc.authorwosid | Zamani, Ayse/A-6567-2016 | |
| dc.authorwosid | Kavakli, Ibrahim/Aaf-5468-2020 | |
| dc.authorwosid | Duran, Tugce/Mgb-2718-2025 | |
| dc.contributor.author | Somuncu, Makbule | |
| dc.contributor.author | Yildirim, Mahmut Selman | |
| dc.contributor.author | Aydin, Cihan | |
| dc.contributor.author | Zamani, Ayse Gul | |
| dc.contributor.author | Albayrak, Esra | |
| dc.contributor.author | Duran, Tugce | |
| dc.contributor.author | Kavakli, Ibrahim Halil | |
| dc.contributor.authorID | Aydın, Cihan/0000-0003-0560-1895 | |
| dc.date.accessioned | 2025-12-11T00:52:14Z | |
| dc.date.issued | 2024 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Somuncu, Makbule; Yildirim, Mahmut Selman; Zamani, Ayse Gul] Necmettin Erbakan Univ, Med Fac Med Genet, Konya, Turkiye; [Aydin, Cihan] Istanbul Medeniyet Univ, Mol Biol & Genet, Mol Microbiol, Konya, Turkiye; [Albayrak, Esra] Ondokuzmayis Univ, Fac Hlth Sci, Dept Med Serv & Tech, Samsun, Turkiye; [Duran, Tugce] Karatay Univ, Fac Med, Konya, Turkiye; [Kavakli, Ibrahim Halil] Koc Univ, Istanbul, Turkiye | en_US |
| dc.description | Aydın, Cihan/0000-0003-0560-1895; | en_US |
| dc.description.sponsorship | [181418003] | en_US |
| dc.description.sponsorship | This project was financed by the budget given for doctoral theses by the scientific research organization of Necmettin Erbakan University, Medicine Faculty, Project number; 181418003). | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded - Conference Proceedings Citation Index - Science | |
| dc.identifier.endpage | 1204 | en_US |
| dc.identifier.issn | 1018-4813 | |
| dc.identifier.issn | 1476-5438 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 1204 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/39847 | |
| dc.identifier.volume | 32 | en_US |
| dc.identifier.wos | WOS:001421430501222 | |
| dc.identifier.wosquality | Q1 | |
| dc.language.iso | en | en_US |
| dc.publisher | SpringerNature | en_US |
| dc.relation.ispartof | European Journal of Human Genetics | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | BCR:ABL1(P210) | en_US |
| dc.subject | CML | en_US |
| dc.subject | CRISPR/Cas9 | en_US |
| dc.title | A New Generation Chronic Myeloid Leukemia Treatment Strategy Through the Utilization of CRISPR/Cas9 Mediated Gene Therapy | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication |
